1107 related articles for article (PubMed ID: 15731895)
1. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
Lees GJ
Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
[TBL] [Abstract][Full Text] [Related]
3. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.
Marino MJ; Conn PJ
Curr Opin Pharmacol; 2006 Feb; 6(1):98-102. PubMed ID: 16368268
[TBL] [Abstract][Full Text] [Related]
4. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
Gannon RL; Millan MJ
Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor ligands as potential therapeutics for addiction.
Olive MF
Curr Drug Abuse Rev; 2009 Jan; 2(1):83-98. PubMed ID: 19630739
[TBL] [Abstract][Full Text] [Related]
6. The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats.
Koltunowska D; Gibula-Bruzda E; Kotlinska JH
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():242-9. PubMed ID: 23623810
[TBL] [Abstract][Full Text] [Related]
7. Ligands for glutamate receptors: design and therapeutic prospects.
Bräuner-Osborne H; Egebjerg J; Nielsen EO; Madsen U; Krogsgaard-Larsen P
J Med Chem; 2000 Jul; 43(14):2609-45. PubMed ID: 10893301
[No Abstract] [Full Text] [Related]
8. Investigation by ion channel domain transplantation of rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit.
Villmann C; Strutz N; Morth T; Hollmann M
Eur J Neurosci; 1999 May; 11(5):1765-78. PubMed ID: 10215929
[TBL] [Abstract][Full Text] [Related]
9. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications.
Trist DG
Pharm Acta Helv; 2000 Mar; 74(2-3):221-9. PubMed ID: 10812962
[TBL] [Abstract][Full Text] [Related]
10. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential.
Kew JN
Pharmacol Ther; 2004 Dec; 104(3):233-44. PubMed ID: 15556676
[TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
Ritzén A; Mathiesen JM; Thomsen C
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):202-13. PubMed ID: 16176554
[TBL] [Abstract][Full Text] [Related]
13. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
Palucha A
Expert Opin Investig Drugs; 2006 Dec; 15(12):1545-53. PubMed ID: 17107280
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective noncompetitive modulators of metabotropic glutamate receptor subtype 1 (mGluR1).
Layton ME
Curr Top Med Chem; 2005; 5(9):859-67. PubMed ID: 16178731
[TBL] [Abstract][Full Text] [Related]
15. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
[TBL] [Abstract][Full Text] [Related]
16. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells.
Morley P; Small DL; Murray CL; Mealing GA; Poulter MO; Durkin JP; Stanimirovic DB
J Cereb Blood Flow Metab; 1998 Apr; 18(4):396-406. PubMed ID: 9538905
[TBL] [Abstract][Full Text] [Related]
17. Activation of NMDA receptors reduces metabotropic glutamate receptor-induced long-term depression in the nucleus accumbens via a CaMKII-dependent mechanism.
Huang CC; Hsu KS
Neuropharmacology; 2012 Dec; 63(8):1298-307. PubMed ID: 22947307
[TBL] [Abstract][Full Text] [Related]
18. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.
Gasparini F; Kuhn R; Pin JP
Curr Opin Pharmacol; 2002 Feb; 2(1):43-9. PubMed ID: 11786307
[TBL] [Abstract][Full Text] [Related]
19. Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.
Tharmalingam S; Burns AR; Roy PJ; Hampson DR
Neuropharmacology; 2012 Sep; 63(4):667-74. PubMed ID: 22652059
[TBL] [Abstract][Full Text] [Related]
20. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
